BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 9293517)

  • 21. Lutein, zeaxanthin, and the macular pigment.
    Landrum JT; Bone RA
    Arch Biochem Biophys; 2001 Jan; 385(1):28-40. PubMed ID: 11361022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stereochemistry of the human macular carotenoids.
    Bone RA; Landrum JT; Hime GW; Cains A; Zamor J
    Invest Ophthalmol Vis Sci; 1993 May; 34(6):2033-40. PubMed ID: 8491553
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye.
    Krinsky NI; Landrum JT; Bone RA
    Annu Rev Nutr; 2003; 23():171-201. PubMed ID: 12626691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nutritional manipulation of primate retinas, I: effects of lutein or zeaxanthin supplements on serum and macular pigment in xanthophyll-free rhesus monkeys.
    Neuringer M; Sandstrom MM; Johnson EJ; Snodderly DM
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3234-43. PubMed ID: 15326146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macular pigment carotenoids in the retina and occipital cortex are related in humans.
    Vishwanathan R; Schalch W; Johnson EJ
    Nutr Neurosci; 2016; 19(3):95-101. PubMed ID: 25752849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration.
    Ciulla TA; Hammond BR
    Am J Ophthalmol; 2004 Oct; 138(4):582-7. PubMed ID: 15488784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dietary modification of human macular pigment density.
    Hammond BR; Johnson EJ; Russell RM; Krinsky NI; Yeum KJ; Edwards RB; Snodderly DM
    Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1795-801. PubMed ID: 9286268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HPLC measurement of ocular carotenoid levels in human donor eyes in the lutein supplementation era.
    Bhosale P; Zhao DY; Bernstein PS
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):543-9. PubMed ID: 17251448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macular pigment imaging in AREDS2 participants: an ancillary study of AREDS2 subjects enrolled at the Moran Eye Center.
    Bernstein PS; Ahmed F; Liu A; Allman S; Sheng X; Sharifzadeh M; Ermakov I; Gellermann W
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6178-86. PubMed ID: 22879423
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the macular pigment by HPLC: retinal distribution and age study.
    Bone RA; Landrum JT; Fernandez L; Tarsis SL
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):843-9. PubMed ID: 3372161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of the validity of in vivo methods of measuring human macular pigment optical density.
    Hammond BR; Wooten BR; Smollon B
    Optom Vis Sci; 2005 May; 82(5):387-404. PubMed ID: 15894915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macular pigment density is reduced in obese subjects.
    Hammond BR; Ciulla TA; Snodderly DM
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):47-50. PubMed ID: 11773011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies.
    Zhao DY; Wintch SW; Ermakov IV; Gellermann W; Bernstein PS
    Arch Ophthalmol; 2003 Jul; 121(7):967-72. PubMed ID: 12860799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Augmentation of macular pigment following implantation of blue light-filtering intraocular lenses at the time of cataract surgery.
    Nolan JM; O'Reilly P; Loughman J; Stack J; Loane E; Connolly E; Beatty S
    Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4777-85. PubMed ID: 19628740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macular pigment density and age-related maculopathy in the Carotenoids in Age-Related Eye Disease Study. An ancillary study of the women's health initiative.
    LaRowe TL; Mares JA; Snodderly DM; Klein ML; Wooten BR; Chappell R;
    Ophthalmology; 2008 May; 115(5):876-883.e1. PubMed ID: 17868874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls.
    Richer S; Devenport J; Lang JC
    Optometry; 2007 May; 78(5):213-9. PubMed ID: 17478338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationships between macular pigment optical density and its constituent carotenoids in diet and serum.
    Nolan JM; Stack J; O'connell E; Beatty S
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):571-82. PubMed ID: 17251452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of age and cataract surgery on macular pigment optic density: a cross-sectional, comparative study.
    Demirel S; Bilici S; Batıoglu F; Ozmert E
    Graefes Arch Clin Exp Ophthalmol; 2014 Feb; 252(2):213-8. PubMed ID: 23873256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A central dip in the macular pigment spatial profile is associated with age and smoking.
    Kirby ML; Beatty S; Loane E; Akkali MC; Connolly EE; Stack J; Nolan JM
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6722-8. PubMed ID: 20592234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary lutein and zeaxanthin: possible effects on visual function.
    Stringham JM; Hammond BR
    Nutr Rev; 2005 Feb; 63(2):59-64. PubMed ID: 15762089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.